Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model.

Symons LK, Miller JE, Tyryshkin K, Monsanto SP, Marks RM, Lingegowda H, Vanderbeck K, Childs T, Young SL, Lessey BA, Koti M, Tayade C.

FASEB J. 2020 Jan;34(1):1558-1575. doi: 10.1096/fj.201902272R. Epub 2019 Dec 2.

PMID:
31914688
2.

Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature.

Khalaj K, Miller JE, Lingegowda H, Fazleabas AT, Young SL, Lessey BA, Koti M, Tayade C.

JCI Insight. 2019 Sep 19;4(18). pii: 128846. doi: 10.1172/jci.insight.128846.

3.

Anesthetic technique and oncological outcomes in urology: A clinical practice review.

Lusty AJ, Hosier GW, Koti M, Chenard S, Mizubuti GB, Jaeger M, Siemens DR.

Urol Oncol. 2019 Dec;37(12):845-852. doi: 10.1016/j.urolonc.2019.08.004. Epub 2019 Sep 13. Review.

PMID:
31526652
4.

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.

Vidotto T, Nersesian S, Graham C, Siemens DR, Koti M.

J Immunother Cancer. 2019 Jun 7;7(1):148. doi: 10.1186/s40425-019-0619-8.

5.

PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.

Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Picanço de Albuquerque CG, Reis RB, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M.

Prostate. 2019 Jun;79(9):969-979. doi: 10.1002/pros.23808. Epub 2019 Apr 18.

PMID:
30999388
6.

The Tumor Immune Contexture of Prostate Cancer.

Vitkin N, Nersesian S, Siemens DR, Koti M.

Front Immunol. 2019 Mar 28;10:603. doi: 10.3389/fimmu.2019.00603. eCollection 2019. Review.

7.

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.

Yu A, Mansure JJ, Solanki S, Siemens DR, Koti M, Dias ABT, Burnier MM, Brimo F, Kassouf W.

PLoS One. 2018 Oct 11;13(10):e0205746. doi: 10.1371/journal.pone.0205746. eCollection 2018.

8.

Diversifying our research portfolio: A conversation with an early career investigator.

Siemens DR, Koti M.

Can Urol Assoc J. 2018 Aug;12(8):223-224. doi: 10.5489/cuaj.5524. No abstract available.

9.

The Immunopathophysiology of Endometriosis.

Symons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, Tayade C.

Trends Mol Med. 2018 Sep;24(9):748-762. doi: 10.1016/j.molmed.2018.07.004. Epub 2018 Jul 24. Review.

PMID:
30054239
10.

STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer.

Ghaffari A, Peterson N, Khalaj K, Vitkin N, Robinson A, Francis JA, Koti M.

Br J Cancer. 2018 Aug;119(4):440-449. doi: 10.1038/s41416-018-0188-5. Epub 2018 Jul 26.

11.

Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome.

Clifford C, Vitkin N, Nersesian S, Reid-Schachter G, Francis JA, Koti M.

Am J Reprod Immunol. 2018 Aug;80(2):e12975. doi: 10.1111/aji.12975. Epub 2018 May 21. Review.

PMID:
29781548
12.

Erratum: Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.

Koti M, Xu AS, Ren KYM, Visram K, Ren R, Berman DM, Siemens DR.

Bladder Cancer. 2018 Jan 20;4(1):137. doi: 10.3233/BLC-189029.

13.

Increased STAT1 Expression in High Grade Serous Ovarian Cancer Is Associated With a Better Outcome.

Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Candido Dos Reis FJ, de Sousa CB, Tiezzi DG, de Andrade JM, Koti M, Squire JA.

Int J Gynecol Cancer. 2018 Mar;28(3):459-465. doi: 10.1097/IGC.0000000000001193.

PMID:
29303938
14.

Interleukin-33 modulates inflammation in endometriosis.

Miller JE, Monsanto SP, Ahn SH, Khalaj K, Fazleabas AT, Young SL, Lessey BA, Koti M, Tayade C.

Sci Rep. 2017 Dec 20;7(1):17903. doi: 10.1038/s41598-017-18224-x.

15.

Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.

Koti M, Xu AS, Ren KYM, Visram K, Ren R, Berman DM, Siemens DR.

Bladder Cancer. 2017 Oct 27;3(4):259-267. doi: 10.3233/BLC-170120. Erratum in: Bladder Cancer. 2018 Jan 20;4(1):137.

16.

Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance.

Ren R, Tyryshkin K, Graham CH, Koti M, Siemens DR.

Oncotarget. 2017 Aug 9;8(41):70982-71001. doi: 10.18632/oncotarget.20237. eCollection 2017 Sep 19.

17.

A balancing act: RNA binding protein HuR/TTP axis in endometriosis patients.

Khalaj K, Ahn SH, Bidarimath M, Nasirzadeh Y, Singh SS, Fazleabas AT, Young SL, Lessey BA, Koti M, Tayade C.

Sci Rep. 2017 Jul 19;7(1):5883. doi: 10.1038/s41598-017-06081-7.

18.

RNA-Binding Proteins in Female Reproductive Pathologies.

Khalaj K, Miller JE, Fenn CR, Ahn S, Luna RL, Symons L, Monsanto SP, Koti M, Tayade C.

Am J Pathol. 2017 Jun;187(6):1200-1210. doi: 10.1016/j.ajpath.2017.01.017. Epub 2017 Apr 11. Review.

19.

CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.

K Au K, Peterson N, Truesdell P, Reid-Schachter G, Khalaj K, Ren R, Francis JA, Graham CH, Craig AW, Koti M.

Gynecol Oncol. 2017 Jun;145(3):436-445. doi: 10.1016/j.ygyno.2017.03.007. Epub 2017 Mar 17.

PMID:
28318643
20.

Extracellular vesicle mediated intercellular communication at the porcine maternal-fetal interface: A new paradigm for conceptus-endometrial cross-talk.

Bidarimath M, Khalaj K, Kridli RT, Kan FW, Koti M, Tayade C.

Sci Rep. 2017 Jan 12;7:40476. doi: 10.1038/srep40476.

21.

STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer.

Au KK, Le Page C, Ren R, Meunier L, Clément I, Tyrishkin K, Peterson N, Kendall-Dupont J, Childs T, Francis JA, Graham CH, Craig AW, Squire JA, Mes-Masson AM, Koti M.

J Pathol Clin Res. 2016 Sep 19;2(4):259-270. eCollection 2016 Oct.

22.

Implications of immune dysfunction on endometriosis associated infertility.

Miller JE, Ahn SH, Monsanto SP, Khalaj K, Koti M, Tayade C.

Oncotarget. 2017 Jan 24;8(4):7138-7147. doi: 10.18632/oncotarget.12577. Review.

23.

Altered expression of chemokines and their receptors at porcine maternal-fetal interface during early and mid-gestational fetal loss.

Bidarimath M, Khalaj K, Kridli RT, Wessels JM, Koti M, Tayade C.

Cell Tissue Res. 2016 Dec;366(3):747-761. Epub 2016 Aug 8.

PMID:
27503377
24.

Immune-inflammation gene signatures in endometriosis patients.

Ahn SH, Khalaj K, Young SL, Lessey BA, Koti M, Tayade C.

Fertil Steril. 2016 Nov;106(6):1420-1431.e7. doi: 10.1016/j.fertnstert.2016.07.005. Epub 2016 Jul 27.

25.

A primer on tumour immunology and prostate cancer immunotherapy.

Ren R, Koti M, Hamilton T, Graham CH, Nayak JG, Singh J, Drachenberg DE, Siemens DR.

Can Urol Assoc J. 2016 Jan-Feb;10(1-2):60-5. doi: 10.5489/cuaj.3418. Review. No abstract available.

26.

Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis.

Black M, Barsoum IB, Truesdell P, Cotechini T, Macdonald-Goodfellow SK, Petroff M, Siemens DR, Koti M, Craig AW, Graham CH.

Oncotarget. 2016 Mar 1;7(9):10557-67. doi: 10.18632/oncotarget.7235.

27.

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.

Koti M, Siu A, Clément I, Bidarimath M, Turashvili G, Edwards A, Rahimi K, Mes-Masson AM, Squire JA.

Br J Cancer. 2015 Dec 22;113(12):1746. doi: 10.1038/bjc.2015.459. No abstract available.

28.

Current state of biomarkers in ovarian cancer prognosis.

Au KK, Josahkian JA, Francis JA, Squire JA, Koti M.

Future Oncol. 2015;11(23):3187-95. doi: 10.2217/fon.15.251. Epub 2015 Nov 9. Review.

PMID:
26551891
29.

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.

Koti M, Siu A, Clément I, Bidarimath M, Turashvili G, Edwards A, Rahimi K, Mes-Masson AM, Squire JA.

Br J Cancer. 2015 Mar 31;112(7):1215-22. doi: 10.1038/bjc.2015.81. Erratum in: Br J Cancer. 2015 Dec 22;113(12):1746. Masson, A-M M [corrected to Mes-Masson, A-M].

30.

Mechanisms of hypoxia-mediated immune escape in cancer.

Barsoum IB, Koti M, Siemens DR, Graham CH.

Cancer Res. 2014 Dec 15;74(24):7185-90. doi: 10.1158/0008-5472.CAN-14-2598. Epub 2014 Oct 24.

31.

Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.

Martin JW, Chilton-MacNeill S, Koti M, van Wijnen AJ, Squire JA, Zielenska M.

PLoS One. 2014 May 16;9(5):e95843. doi: 10.1371/journal.pone.0095843. eCollection 2014.

32.

Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer.

Koti M, Gooding RJ, Nuin P, Haslehurst A, Crane C, Weberpals J, Childs T, Bryson P, Dharsee M, Evans K, Feilotter HE, Park PC, Squire JA.

BMC Cancer. 2013 Nov 16;13:549. doi: 10.1186/1471-2407-13-549.

33.

Exploring high dimensional data with Butterfly: a novel classification algorithm based on discrete dynamical systems.

Geraci J, Dharsee M, Nuin P, Haslehurst A, Koti M, Feilotter HE, Evans K.

Bioinformatics. 2014 Mar 1;30(5):712-8. doi: 10.1093/bioinformatics/btt602. Epub 2013 Oct 21.

PMID:
24149051
34.

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S, Squire J, Park PC, Feilotter H.

BMC Cancer. 2012 Mar 19;12:91. doi: 10.1186/1471-2407-12-91.

35.

Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer.

Weberpals JI, Koti M, Squire JA.

Cancer Genet. 2011 Oct;204(10):525-35. doi: 10.1016/j.cancergen.2011.09.004. Review.

PMID:
22137482
36.

A single point mutation in framework region 3 of heavy chain affects viral neutralization dynamics of single-chain Fv against bovine herpes virus type 1.

Koti M, Nagy E, Kaushik AK.

Vaccine. 2011 Oct 19;29(45):7905-12. doi: 10.1016/j.vaccine.2011.08.077. Epub 2011 Aug 26.

PMID:
21872632
37.

Novel atypical nucleotide insertions specifically at VH-DH junction generate exceptionally long CDR3H in cattle antibodies.

Koti M, Kataeva G, Kaushik AK.

Mol Immunol. 2010 Jul;47(11-12):2119-28. doi: 10.1016/j.molimm.2010.02.014.

PMID:
20435350
38.

Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1.

Koti M, Farrugia W, Nagy E, Ramsland PA, Kaushik AK.

Mol Immunol. 2010 Feb;47(5):953-60. doi: 10.1016/j.molimm.2009.11.011. Epub 2009 Dec 16.

PMID:
20006385
39.

Reducing stroke rates in patients with atrial fibrillation: how low can we go?

Ezekowitz MD, Koti MJ, Fulton B.

Circulation. 2009 Sep 29;120(13):1169-70. doi: 10.1161/CIRCULATIONAHA.109.893438. Epub 2009 Sep 14. No abstract available.

PMID:
19752317
40.

A multilobed osteochondroma of the hamate: case report.

Koti M, Honakeri SP, Thomas A.

J Hand Surg Am. 2009 Oct;34(8):1515-7. doi: 10.1016/j.jhsa.2009.04.029. Epub 2009 Aug 20.

PMID:
19695798
41.

Clinical images.

Shaw JA, Koti M.

CMAJ. 2009 Apr 14;180(8):895. doi: 10.1503/cmaj.071335. No abstract available.

42.

Somatic hypermutations and isotype restricted exceptionally long CDR3H contribute to antibody diversification in cattle.

Kaushik AK, Kehrli ME Jr, Kurtz A, Ng S, Koti M, Shojaei F, Saini SS.

Vet Immunol Immunopathol. 2009 Jan 15;127(1-2):106-13. doi: 10.1016/j.vetimm.2008.09.024. Epub 2008 Oct 5.

PMID:
19012969
43.

Organization of D(H)-gene locus is distinct in cattle.

Koti M, Kataeva G, Kaushik AK.

Dev Biol (Basel). 2008;132:307-313. doi: 10.1159/000317176.

PMID:
18817318
44.

Painful disc lesion: can modern biplanar magnetic resonance imaging replace discography?

Lei D, Rege A, Koti M, Smith FW, Wardlaw D.

J Spinal Disord Tech. 2008 Aug;21(6):430-5. doi: 10.1097/BSD.0b013e318153f7e4.

PMID:
18679099
46.

L-arginine stimulates immune response in chickens immunized with intermediate plus strain of infectious bursal disease vaccine.

Tayade C, Jaiswal TN, Mishra SC, Koti M.

Vaccine. 2006 Jan 30;24(5):552-60. Epub 2005 Aug 31.

PMID:
16168528
47.

Tailor's bunion: a review.

Ajis A, Koti M, Maffulli N.

J Foot Ankle Surg. 2005 May-Jun;44(3):236-45. Review.

PMID:
15940605
48.

Restriction enzyme analysis of Indian isolates of egg drop syndrome 1976 virus recovered from chicken, duck and quail.

Senthilkumar N, Kataria JM, Koti M, Dhama K, Dash BB.

Vet Res Commun. 2004 Jul;28(5):447-53.

PMID:
15379439
49.
50.

Scott wiring for direct repair of lumbar spondylolysis.

Askar Z, Wardlaw D, Koti M.

Spine (Phila Pa 1976). 2003 Feb 15;28(4):354-7.

PMID:
12590209

Supplemental Content

Support Center